Brind.

Citigroup and Raymond James Financial published research reports and price targets for a company whose stock trades on the Nasdaq platform.

13 reports, 3 independent Updated Sep 8
Gone quiet
Reports
13
Developments
6
Repetition
85%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Citigroup and Raymond James Financial published research reports and price targets for a company whose stock trades on the Nasdaq platform.

Who's involved

What this event is mainly about
CitigroupRaymond James FinancialMarketScreener

How it developed

Newest first. Tap a step to see who reported it.
  1. Citigroup and Raymond James Financial initiated coverage of Rapport Therapeutics with rating upgrades.1 source
  2. Citigroup increased its price target on SunocoCorp LLC, while Raymond James Financial reaffirmed its strong-buy rating on the company.Sub-event
  3. Raymond James Financial raised shares of Walt Disney.Sub-event
  4. Citigroup provided rating and price targets for ProQR Therapeutics stock.Sub-event
  5. Raymond James Financial, Boston Partners, and GQG Partners raised holdings in Allstate, and Citigroup boosted its target price on the company.Sub-event
  6. Research reports published on the stock price of company APA.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
7 more outlets ran the same wire story